Log in

RegulatoryCNBC-TV18

Alkem Laboratories gets USFDA warning letter with OAI classification for Daman facility

Negative-64

GreyOak summary

Alkem Laboratories received a USFDA warning letter regarding its Daman facility after an inspection. The company stated it will take corrective actions but continues manufacturing.

What it affects

Source

Read the original at CNBC-TV18

More Alkem Laboratories news

All Alkem Laboratories news →

The company today

Price, day change, sector and market cap of the companies this story names
CompanyPriceDay changeSectorMarket cap
Alkem LaboratoriesALKEM · NSE₹5,145.00−1.48%Healthcare₹61,516 crore

Prices as of ; the last session's close when the market is shut. Research, not investment advice.

Latest market news

News Intelligence →

We use cookies

Essential cookies keep GreyOak secure and functional. Optional cookies help improve your experience and platform performance. You can update your preferences anytime.

Cookie Policy